Gender (male/female), n (%) | 49 (45)/59 (55) |
Age (years) | 44±8 (42 to 45) |
Height (cm) | 170±9 (168 to 172) |
Weight (kg) | 71.5±15 (68 to 75) |
Disease course, n (%) | |
Relapsing-remitting | 80 (74) |
Secondary progressive | 19 (18) |
Primary progressive | 8 (8) |
Disease duration (years) | 12.5±8.0 (11.0 to 14.2) |
EDDS (0–10) | 3.4±1.7 (3.1 to 3.8) |
FIS (total score, 0–84) | 38.7±19.2 (34.9 to 42.5) |
Physical function (SF-36, 0–100) | 55.5±27.8 (49.9 to 60.9) |
Physical role (SF-36, 0–100) | 49.5±40.7 (41.4 to 57.6) |
Bodily pain (SF-36, 0–100) | 66.2±23.5 (62.5 to 70.8) |
General health (SF-36, 0–100) | 44.8±21.1 (40.6 to 49.1) |
Vitality (SF-36, 0–100) | 44.9±19.8 (40.9 to 48.8) |
Social function (SF-36, 0–100) | 71.2±24.2 (66.4 to 76.0) |
Emotional role (SF-36, 0–100) | 78.3±35.9 (71.2 to 85.4) |
Mental health (SF-36, 0–100) | 68.6±16.4 (65.4 to 71.9) |
BDI-II (0–63) | 10.2±6.7 (8.8 to 11.5) |
*Data are mean±SD (95% CI).
BDI-II, Beck Depression Inventory-II; EDSS, Expanded Disability Status Scale; FIS, Fatigue Impact Scale; SF-36, Short-Form Health Survey 36.